The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 16, 2018

Filed:

Dec. 01, 2015
Applicant:

The Wistar Institute of Anatomy and Biology, Philadelphia, PA (US);

Inventors:

Hui Hu, Wynnewood, PA (US);

Jose R. Conejo-Garcia, Philadelphia, PA (US);

Tom-Li Stephen, Philadelphia, PA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/17 (2015.01); A61K 48/00 (2006.01); C12N 15/113 (2010.01); A61K 39/00 (2006.01); A61K 31/713 (2006.01); A61K 38/20 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); A61N 5/10 (2006.01); A61K 47/59 (2017.01);
U.S. Cl.
CPC ...
C12N 15/113 (2013.01); A61K 31/713 (2013.01); A61K 35/17 (2013.01); A61K 38/2046 (2013.01); A61K 39/0011 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61K 47/595 (2017.08); A61N 5/10 (2013.01); A61K 48/005 (2013.01); A61K 2039/5156 (2013.01); A61K 2039/5158 (2013.01); C12N 2310/14 (2013.01); C12N 2310/531 (2013.01); C12N 2330/50 (2013.01); C12N 2740/16043 (2013.01);
Abstract

Compositions, e.g., therapeutic agents, and methods are provided for modulating gene and protein expression of Forkhead Box protein 1 (Foxp1). The therapeutic agents include short nucleic acid molecules that modulate gene and protein expression of Forkhead Box protein 1 (Foxp1) expression, viral vectors containing such molecules, T cells transduced with these viruses for adoptive therapies, and any small molecules that bind to and inactivate Foxp1. These compounds and methods have applications in cancer therapy either alone or in combination with other therapies that stimulate the endogenous immune system in the environment of the cancer, e.g., tumor.


Find Patent Forward Citations

Loading…